Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastro-enteropancreatic neuroendocrine tumor 8Neuroendocrine Tumors 4Pancreatic Neoplasms 2Stomach Neoplasms 1Pheochromocytoma 1Paraganglioma 1Pancreatic Diseases 1Neuroectodermal Tumors 1Neoplasms, Nerve Tissue 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasms 1Intestinal Neoplasms 1Intestinal Diseases 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1Digestive System Neuroendocrine Tumor G1 1Digestive System Neoplasms 1Digestive System Diseases 1Adenoma, Islet Cell 1

Interventions

Sunitinib 5Specimen Handling 2Magnetic Resonance Spectroscopy 2Endoscopic Ultrasound-Guided Fine Needle Aspiration 2sapanisertib 1napabucasin 1lutetium Lu 177 dotatate 1lanreotide 1irinotecan sucrosofate 1cabozantinib 1aflibercept 1abemaciclib 1X-Rays 1Wound Healing 1Taxes 1Plastic Surgery Procedures 1Phantoms, Imaging 1Paclitaxel 1Oxaliplatin 1Octreotide 1Methods 1Melphalan 1Leucovorin 1Irinotecan 1Histocompatibility Testing 1Gemcitabine 1Fluorouracil 1Everolimus 1Cytoreduction Surgical Procedures 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenoma, Islet Cell × lutetium Lu 177 dotatate × Gastrointestinal × Clear all
NCT05687123 2026-05-13

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

National Cancer Institute (NCI)

Phase 1 Recruiting
24 enrolled
Gastrointestinal

Adenoma, Islet Cell, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡